Topiramate Pregnancy Prevention Programme Annual Risk Awareness Form Topiramate should not be used in patients of childbearing potential unless the conditions of the Pregnancy Prevention Programme are fulfilled. This form outlines the condition of the topiramate Pregnancy Prevention Programme and when these must be fulfilled. This form should be used to support and record the prescribing decision.

Topiramate Pregnancy Prevention Programme Annual Risk Awareness Form - Prophylaxis of Migraine Topiramate should not be used in patients of childbearing potential unless the conditions of the Pregnancy Prevention Programme are fulfilled. This form outlines the conditions of the topiramate Pregnancy Prevention Programme and when these must be fulfilled. The form should be used to support and record the prescribing decision.

Topiramate Pregnancy Prevention Programme Information on the risks of topiramate use in girls (of any age) and women of childbearing potential in the treatment of epilepsy.

Topiramate Pregnancy Prevention Programme Information on the risks of topiramate use in women of childbearing potential in the treatment of prophylaxis of migraine

Important information for all female patients who could become pregnant

Topiramate Pregnancy Prevention Programme - Patient Guide: What patients who are able to get pregnant need to know about topiramate

Topiramate Pregnancy Prevention Programme Patient Guide: What patients who are able to get pregnant need to know about topiramate

Sticker for Pharmacies - WARNING FOR WOMEN WHO ARE ABLE TO BECOME PREGNANT